Ralf Amann

408 total citations
26 papers, 290 citations indexed

About

Ralf Amann is a scholar working on Infectious Diseases, Genetics and Virology. According to data from OpenAlex, Ralf Amann has authored 26 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 13 papers in Genetics and 11 papers in Virology. Recurrent topics in Ralf Amann's work include Virus-based gene therapy research (13 papers), Poxvirus research and outbreaks (10 papers) and Viral gastroenteritis research and epidemiology (7 papers). Ralf Amann is often cited by papers focused on Virus-based gene therapy research (13 papers), Poxvirus research and outbreaks (10 papers) and Viral gastroenteritis research and epidemiology (7 papers). Ralf Amann collaborates with scholars based in Germany, United States and Switzerland. Ralf Amann's co-authors include Hanns-Joachim Rziha, Melanie Müller, Michael W. Wolff, R. Raue, Zsofia Bittner, Shilpa Elizabeth George, Mathias Büttner, Michael Ghosh, Markus Löffler and Martin Hardt and has published in prestigious journals such as PLoS ONE, Journal of Virology and Frontiers in Immunology.

In The Last Decade

Ralf Amann

24 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralf Amann Germany 9 135 127 108 92 70 26 290
Catherine A. Cotter United States 12 124 0.9× 130 1.0× 231 2.1× 149 1.6× 181 2.6× 18 439
Ann N. Rosenthal United States 7 93 0.7× 135 1.1× 188 1.7× 47 0.5× 145 2.1× 9 352
Elizabeth S. C. P. Williams United States 10 53 0.4× 96 0.8× 29 0.3× 70 0.8× 32 0.5× 17 264
Rolf Suter United States 7 66 0.5× 121 1.0× 48 0.4× 188 2.0× 93 1.3× 8 359
Dengyun Sun United States 11 87 0.6× 143 1.1× 31 0.3× 87 0.9× 210 3.0× 14 377
Fiona T. van den Berg South Africa 5 79 0.6× 152 1.2× 26 0.2× 275 3.0× 80 1.1× 6 421
Zhaochen Luo China 13 73 0.5× 181 1.4× 168 1.6× 72 0.8× 96 1.4× 20 382
Anna Kushnir United States 10 56 0.4× 168 1.3× 48 0.4× 194 2.1× 237 3.4× 12 487
Ang Bian United States 7 251 1.9× 157 1.2× 78 0.7× 145 1.6× 180 2.6× 9 492
Diana Edo-Matas Netherlands 11 51 0.4× 160 1.3× 189 1.8× 90 1.0× 56 0.8× 15 307

Countries citing papers authored by Ralf Amann

Since Specialization
Citations

This map shows the geographic impact of Ralf Amann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Amann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Amann more than expected).

Fields of papers citing papers by Ralf Amann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Amann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Amann. The network helps show where Ralf Amann may publish in the future.

Co-authorship network of co-authors of Ralf Amann

This figure shows the co-authorship network connecting the top 25 collaborators of Ralf Amann. A scholar is included among the top collaborators of Ralf Amann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf Amann. Ralf Amann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Müller, Melanie, et al.. (2025). Heterologous ORFV–Ad26 vaccination broadens antibody breadth and amplifies cellular immunity against SARS-CoV-2 spike. Frontiers in Immunology. 16. 1715442–1715442.
2.
Amann, Ralf, et al.. (2025). Advancing ORFV‐Based Therapeutics to the Clinical Stage. Reviews in Medical Virology. 35(3). e70038–e70038. 2 indexed citations
3.
Müller, Melanie, Anna‐Friederike Marx, Ingrid Wagner, et al.. (2025). Orf virus-based vectors induce potent germinal center B cell, Tfh cell, and CD8+ T cell responses. Molecular Therapy. 33(11). 5383–5400.
4.
Müller, Melanie, et al.. (2025). Heterologous prime-boost vaccination with VLA2001 and an ORFV-based vector enhances spike- and nucleocapsid-specific immunity in mice. Frontiers in Immunology. 16. 1675859–1675859. 1 indexed citations
5.
Müller, Melanie, Dominique J. Burri, Hanns-Joachim Rziha, et al.. (2024). A multiantigenic Orf virus-based vaccine efficiently protects hamsters and nonhuman primates against SARS-CoV-2. npj Vaccines. 9(1). 191–191. 4 indexed citations
6.
Müller, Melanie, et al.. (2024). Pharmacokinetic and Environmental Risk Assessment of Prime-2-CoV, a Non-Replicating Orf Virus-Based Vaccine against SARS-CoV-2. Vaccines. 12(5). 492–492. 6 indexed citations
7.
Esen, Meral, Julian Gabor, Sabine Bélard, et al.. (2024). First-in-Human Phase I Trial to Assess the Safety and Immunogenicity of an Orf Virus-Based COVID-19 Vaccine Booster. Vaccines. 12(11). 1288–1288. 3 indexed citations
8.
Burri, Dominique J., et al.. (2024). Novel Multi-Antigen Orf-Virus-Derived Vaccine Elicits Protective Anti-SARS-CoV-2 Response in Monovalent and Bivalent Formats. Vaccines. 12(5). 490–490. 3 indexed citations
9.
Amann, Ralf, et al.. (2024). Efficient and scalable clarification of Orf virus from HEK suspension for vaccine development. Vaccine X. 18. 100474–100474. 6 indexed citations
10.
Schunk, Mirjam, John Ervin, Christoph Schindler, et al.. (2024). A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunity. Human Vaccines & Immunotherapeutics. 20(1). 2410574–2410574. 3 indexed citations
11.
Amann, Ralf, et al.. (2023). Stability studies for the identification of critical process parameters for a pharmaceutical production of the Orf virus. Vaccine. 41(32). 4731–4742. 5 indexed citations
12.
Amann, Ralf, et al.. (2023). An investigation of excipients for a stable Orf viral vector formulation. Virus Research. 336. 199213–199213. 3 indexed citations
13.
14.
Rziha, Hanns-Joachim, et al.. (2022). Comparison of sample preparation techniques for the physicochemical characterization of Orf virus particles. Journal of Virological Methods. 310. 114614–114614. 6 indexed citations
15.
16.
17.
Hardt, Martin, et al.. (2020). A scalable downstream process for the purification of the cell culture-derived Orf virus for human or veterinary applications. Journal of Biotechnology. 323. 221–230. 20 indexed citations
18.
Rziha, Hanns-Joachim, et al.. (2019). Genomic Characterization of Orf Virus Strain D1701-V (Parapoxvirus) and Development of Novel Sites for Multiple Transgene Expression. Viruses. 11(2). 127–127. 30 indexed citations
19.
20.
Amann, Ralf, et al.. (2013). New Orf Virus (Parapoxvirus) Recombinant Expressing H5 Hemagglutinin Protects Mice against H5N1 and H1N1 Influenza A Virus. PLoS ONE. 8(12). e83802–e83802. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catherine A. Cotter Breakdown of academic impact, for papers by Ann N. Rosenthal Breakdown of academic impact, for papers by Elizabeth S. C. P. Williams Breakdown of academic impact, for papers by Rolf Suter Breakdown of academic impact, for papers by Dengyun Sun Breakdown of academic impact, for papers by Fiona T. van den Berg Breakdown of academic impact, for papers by Zhaochen Luo Breakdown of academic impact, for papers by Anna Kushnir Breakdown of academic impact, for papers by Ang Bian Breakdown of academic impact, for papers by Diana Edo-Matas
Rankless by CCL
2026